Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 1.00 |
| ▸ | LTA4H | P09960 | 5/20 | 0.85 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.61 |
| ▸ | RARB | P10826 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337960 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL2675357 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL337505 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL337790 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1834632 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1835315 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1401769 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL4238973 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL21054750 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL57745 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693727-B | Catalyst for olefin polymerization and application thereof | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-116693728-B | Solid catalyst component, preparation method thereof, olefin polymerization catalyst and application thereof | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-116606390-B | Olefin polymerization catalyst and application thereof | 中国石油化工股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-116606391-B | Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-115838447-B | Catalyst component for olefin polymerization, preparation method and application thereof, catalyst and application thereof | 中国石油化工股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116693727-A | Catalyst for olefin polymerization and application thereof | 中国石油化工股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116693728-A | Solid catalyst component, preparation method thereof, olefin polymerization catalyst and application thereof | 中国石油化工股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116606390-A | Olefin polymerization catalyst and application thereof | 中国石油化工股份有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116606391-A | Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-106188529-B | A kind of long-chain branch polyphenylene oxide anionic membrane and preparation method thereof | 大连理工大学 | 2018-04-10 | — | — | CN | claimed |
| CN-106188529-A | A kind of long-chain branch polyphenylene oxide anionic membrane and preparation method thereof | 大连理工大学 | 2016-12-07 | — | — | CN | claimed |
| EP-3053992-A1 | Biodiesel | LANXESS Deutschland GmbH (DE) | 2016-08-10 | — | — | EP | claimed |
| EP-0954566-B1 | NONOXYNOL-CONTAINING LIPID VESICLES WITH ANTI-VIRAL AND SPERMACIDAL ACTIVITY | NOVAVAX INC (US) | 2004-07-14 | — | — | EP | claimed |
| EP-0954566-A4 | NONOXYNOL-CONTAINING LIPID VESICLES WITH ANTI-VIRAL AND SPERMACIDAL ACTIVITY | NOVAVAX INC (US) | 2001-11-28 | — | — | EP | claimed |
| EP-0954566-A1 | NONOXYNOL-CONTAINING LIPID VESICLES WITH ANTI-VIRAL AND SPERMACIDAL ACTIVITY | NOVAVAX, INC. (US) | 1999-11-10 | — | — | EP | claimed |
| CN-1226924-A | Monoxynol-containing lipid vesicles with anti-viral and spermacidal activity | NOVAVAX INC (US) | 1999-08-25 | — | — | CN | claimed |
| US-5700679-A | CONTRACEPTIVES | NOVAVAX, INC. (US) | 1997-12-23 | — | — | US | claimed |
| WO-1997046667-A1 | NONOXYNOL-CONTAINING LIPID VESICLES WITH ANTI-VIRAL AND SPERMACIDAL ACTIVITY | NOVAVAX, INC. (US) | 1997-12-11 | — | — | WO | claimed |
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | BASF SE (DE) | 2025-08-05 | — | — | US | disclosed |
| US-3993848-A | ELECTROLESS PLATING, STANNOUS AND COPPER IONS | SURFACE TECHNOLOGY, INC. (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | DHPS, UNG, UMPS | NR5A1 2592/4885LTA4H 1407/4885TP53 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.